GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Mmp9 | increases activity | EXP | | 6480464 | CTD | Norepinephrine results in increased activity of MMP9 protein | PMID:16864425 | Mmp9 | increases expression | EXP | | 6480464 | CTD | Norepinephrine results in increased expression of MMP9 mRNA | PMID:16864425 | Mmp9 | multiple interactions | EXP | | 6480464 | CTD | trans-sodium crocetinate inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] | PMID:16864425 | Mmp9 | increases activity | ISO | MMP9 (Homo sapiens) | 6480464 | CTD | Norepinephrine results in increased activity of MMP9 protein | PMID:24929186 | Mmp9 | increases expression | ISO | MMP9 (Homo sapiens) | 6480464 | CTD | Norepinephrine results in increased expression of MMP9 mRNA | PMID:24929186 | Mmp9 | multiple interactions | ISO | MMP9 (Homo sapiens) | 6480464 | CTD | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]; Propranolol inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]; Propranolol inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]; quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]; quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]; SR 11302 inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]; tanshinone inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] | PMID:24929186 | |
Go Back to source page | Continue to Ontology report |